Navigation Links
Highly Medicated Young Adults at Significant Risk for Misuse, Potential Diversion of Prescription Amphetamines
Date:9/6/2013

BALTIMORE, Sept. 6, 2013 /PRNewswire/ -- Ameritox, the nation's leader in pain medication monitoring, announced new research today showing a correlation between misuse of prescription amphetamines and positive tests for cocaine, marijuana and non-prescribed medications among chronic pain medication users. Ameritox's research was presented yesterday at PAINWeek in Las Vegas.

Ameritox studied nearly 1.5 million urine samples from a nationwide pool of chronic pain patients on prescription opioid therapy. Of those, more than 30,000 samples were from people also prescribed amphetamines such as Adderall, Dexedrine, ProCentra and Vyvanse. The study considered a person an amphetamine misuser if: the patient was prescribed an amphetamine but his urine drug test did not detect one; or the patient did not have an amphetamine prescription but the urine drug test detected one.  Patients who were not misusers of amphetamines had marijuana present 10 percent of the time. The rate of marijuana use nearly doubled among misusers to 18.5 percent.

The most at-risk age group for misuse of amphetamines were those of "college age":  More than 50 percent of samples collected from patients between the ages of 18 and 25 did not contain the amphetamine that the doctor prescribed, based on urine drug monitoring results. Among all patients prescribed an amphetamine, the prescribed stimulant was not found 35.4 percent of the time.

"Our research has shown that there is a clear correlation between misuse of prescription amphetamines and illicit drug use," said Kathryn Bronstein, Ameritox Vice President of Medical Affairs. "Past studies have also concluded that positive marijuana tests and higher rates of prescription drug non-adherence go hand in hand."

A report released last month by the Substance Abuse and Mental Health Services Administration demonstrated the danger of non-medical use of central nervous system stimulants, such as those medications in the Ameritox study. Emergency room visits related to these stimulants increased 300 percent between 2005 and 2011, SAMHSA reported.

"A lot of these stimulants are getting into the wrong hands," Bronstein said. "This reinforces the value of medication monitoring, to help clinicians determine if the patients being prescribed these drugs are actually taking them and to help keep these drugs away from recreational users."

Additional information on the methods, design and results of the research are available at Ameritox.com/research.

About Ameritox

Ameritox is the nation's leader in Pain Medication Monitoring SolutionsSM, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with the information and support they need to enhance and optimize the care of chronic pain patients. Monitoring through prescription drug testing can help physicians make more informed clinical decisions while also helping to reduce the possible risk of misuse, abuse or diversion of powerful medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas and Greensboro, N.C. Ameritox can be found online at www.ameritox.com, on Twitter @Ameritox, on Facebook at facebook.com/ameritox, and on YouTube at www.youtube.com/ameritox.

© 2013 Ameritox Ltd. All rights reserved. Ameritox, Ameritox-Medication Monitoring Solutions, Rx Guardian, Rx Guardian INSIGHT and Rx Guardian CD are trademarks of Ameritox. Other trademarks are the property of their owners.


'/>"/>
SOURCE Ameritox
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unigene and Tarix Pharmaceuticals Report Highly Increased Oral Bioavailability of "Peptelligence-engineered" TXA127
2. American Academy of Pain Medicine Safe Opioid Prescribing Course Proves Highly Effective
3. Acuo Technologies Rated Highly by Customers in PeerIntel Survey
4. Frost & Sullivan: Appropriate Channel Partners Vital in the Highly Fragmented Medical Devices Distribution Market in VITSK
5. NeuroVive Acquires Highly Potent, Novel Cyclophilin Inhibitors From Biotica
6. Rheumatoid Arthritis Patients are Moderately to Highly Satisfied with Their Current Drug Therapy, Rating Conventional DMARDs Highest on Ease of Use and Cost
7. Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility
8. Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth
9. Injectable Dose Formulations Highly Impact Global Pharmaceutical Contract Manufacturing Vendor Revenues
10. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
11. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology:
(Date:6/23/2016)... ... June 23, 2016 , ... Representatives of CHA Fertility Centers ... member of their staff, Dr. Joshua J. Berger. As of May 2016, Dr. ... world-renowned facility. , Dr. Berger has received recognition for his research, his teaching and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Horizon Blue Cross Blue Shield ... relief from the crushing burden of sky-high health care costs, Superior Court of ... ruling ( http://www.judiciary.state.nj.us/opinions/a2913-15a2929-15.pdf ) the court provided some analysis of the contracts ...
(Date:6/23/2016)... ... ... As part of an ongoing commitment to encourage living a healthy and ... BCBSNJ) have teamed up with New Jersey native and PGA Tour member Morgan Hoffmann ... lifestyle. , Through Healthy Steps NJ, Hoffmann will share a series of health education ...
(Date:6/23/2016)... ... ... A key metric of this success is the popularity of the Leafedin.org service ... areas that lack the kind of technology and networking framework that LeafedIn.org provide, where ... the marijuana industry, no matter how small or large, and more importantly no matter ...
(Date:6/23/2016)... ... June 23, 2016 , ... King Kullen’s Shop OnLine, the ... to yet another location: Garden City Park. This is the fourth store to be ... grocery delivery service is offered by King Kullen and allows customers to place orders ...
Breaking Medicine News(10 mins):